| Aβ | Amyloid beta |
| ABCA1 | ATP-binding cassette transporter A1 |
| AChE | Acetylcholinesterase |
| AhR | Aryl hydrocarbon receptor |
| AMPK | AMP-activated protein kinase |
| APP | Amyloid precursor protein |
| AR | Androgen receptor |
| ATP | Adenosine triphosphate |
| BrdU+ | Bromodeoxyuridine-positive |
| BMD | Bone mineral density |
| CAT | Catalase |
| CK | Creatine kinase |
| CNS | Central nervous system |
| CSA | Cross-sectional area |
| Cyt C | Cytochrome C |
| DAI | Disease activity index |
| DC | Dendritic cell |
| D-gal | D-galactose |
| DMD | Duchenne muscle dystrophy |
| DSS | Dextran sodium sulphate |
| DXC+ | Doublecortin-positive |
| EA | Ellagic acid |
| EAE | Autoimmune encephalomyelitis |
| ER | Endoplasmic reticulum |
| ET | Ellagitannin(s) |
| FOX | Forkhead box |
| FUNDC1f/f | FUN14 domain-containing protein 1 expressing |
| FUNDC1CKO | FUN14 domain-containing protein 1 knockout |
| GFAP | Glial fibrillary acidic protein |
| GSH-Px | Glutathione peroxidase |
| HCC | Hepatocellular carcinoma |
| HDL | High-density lipoprotein |
| HFD | High-fat diet |
| ICR | Institute of cancer research |
| IDD | Intervertebral disc degeneration |
| IFN-γ | Interferon-γ |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| IL-23 | Interleukin-23 |
| IR | Irradiated |
| I/R | Ischemia-reperfusion |
| LC3II | Microtubule-associated protein 1 light chain 3-II |
| LDH | Lactate dehydrogenase |
| LPS | Lipopolysaccharides |
| LTP | Long term potentiation |
| MAO | Monoamine oxidase |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDA | Malondialdehyde |
| MFF | Mitochondrial fission factor |
| MI | Myocardial infarction |
| miR-34a | MicroRNA-34a |
| MNCs | Mononuclear cells |
| MPO | Myeloperoxidase |
| MuSCs | Muscle stem cells |
| mtDNA | Mitochondrial DNA |
| mTOR | Mammalian target of rapamycin |
| mTOR1 | mTOR complex 1 |
| mUroA | Methylated Urolithin A |
| NAD | Nicotinamide adenine dinucleotide |
| nDNA | Nuclear DNA |
| OCR | Oxygen consumption rate |
| OPG | Osteoprotegerin |
| OVX | Ovariectomised |
| PBS | Phosphate buffered saline |
| PCG-1α | Peroxisome proliferator-activated receptor gamma coactivator-1 alpha |
| PMA | Phorbol myristate acetate |
| Post-MI | Post-myocardial infarction |
| PTP | Permeability transition pore |
| RCT | Randomised controlled trials |
| SOD | Superoxide dismutase |
| T-AOC | Total anti-oxidant capacity |
| TBI | Total body irradiation |
| TFEB | Transcription factor EB |
| Th17 | T-helper 17 |
| TNBS | 2,4,6-Trinitrobenzenesulfonic acid |
| TNFα | Tumour necrosis factor α |
| TSC2 | Tuberous sclerosis complex 2 |
| ULK | UNC-51-like kinase |
| Uro | Urolithin(s) |
| UroA | Urolithin A |
| UroAR | Urolithin AR |
| UroB | Urolithin B |
| UroC | Urolithin C |
| UroD | Urolithin D |